Clinical Trials Directory

Trials / Completed

CompletedNCT06360484

Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus

Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus (HBV), A Cross-Sectional Study

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
National Center for Gastroentestinal and Liver Disease · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Background: Sudan has a high prevalence of hepatitis B surface antigen (HBsAg), exceeding 8%. The prevalence of hepatitis B varies across different regions of Sudan, ranging from 6.8% in central Sudan to as high as 26% in southern Sudan. Hepatitis B virus (HBV) infection can lead to various complications, including cirrhosis, liver failure, and hepatocellular carcinoma (HCC). Hepatitis D virus (HDV) relies on HBV for replication and can accelerate the progression of HBV-related liver diseases, leading to more severe outcomes. This study aims to determine the prevalence of HDV infection among Sudanese patients with HBV-related liver diseases and to investigate the clinical characteristics of patients with HBV/HDV co-infection. Design/Method: This descriptive cross-sectional hospital-based study was conducted at Ibn Sina Specialized Hospital in Sudan between June and September 2022. Ninety HBV patients aged 16 years and above were included. Patients were interviewed using a structured questionnaire, and medical histories and examinations were recorded. Investigations included liver function tests, abdominal ultrasounds, and ELISA for Ant-HDV-IgG

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTinvestigations for Hepatitis D virusInvestigations included liver function tests, abdominal ultrasounds to identify features of chronic liver disease, and evidence of decompensation. ELISA for Ant-HDV-IgG was conducted.

Timeline

Start date
2022-06-01
Primary completion
2022-09-01
Completion
2022-09-10
First posted
2024-04-11
Last updated
2024-04-11

Locations

1 site across 1 country: Sudan

Source: ClinicalTrials.gov record NCT06360484. Inclusion in this directory is not an endorsement.